Foresite Capital Management VI »

Research Alliance Corp Iii shares owned by Foresite Capital Management VI

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Foresite Capital Management VI from 13F filings

Historical chart of Foresite Capital Management VI investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Foresite Capital Management VI

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.2M 300k 10.70

More positions owned by Foresite Capital Management VI

Cg Oncology (CGON)
Alumis (ALMS)
Seaport Therapeutics
Denali Therapeutics (DNLI)
Celldex Therapeutics (CLDX)
Agios Pharmaceuticals (AGIO)
Corvus Pharmaceuticals (CRVS)
Parabilis Medicines
GH Research Ord (GHRS)
Jade Biosciences (JBIO)
Hinge Health Cl A (HNGE)
Kymera Therapeutics (KYMR)
Ataibeckley (ATAI)
Verastem (VSTM)
Beam Therapeutics (BEAM)

View all positions for Foresite Capital Management VI

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Affinity Asset Advisors
Cormorant Asset Management
Silverarc Capital Management
VR Adviser
Foresite Capital Management VI

View all funds holding Research Alliance Corp Iii